The hepatitis B vaccine can reduce your risk of developing the infection. But up to 10% of people may not respond to this vaccine. They may need to take extra steps to avoid hep B exposure. The ...

Hepatitis A typically quickly resolves on its own without treatment. Very rarely, the viral condition may cause serious complications such as liver disease or liver failure, especially in older or ...

A well-characterized positive marker for hepatocellular differentiation would be a useful tool for the diagnosis of hepatocellular carcinoma (HCC). The recently commercially available Hep Par 1 ...

Get set for even more competition in the hepatitis C space. AbbVie’s Mavyret picked up FDA approval on Thursday as an 8-week treatment regardless of genotype, becoming the first such drug with the ...

A screening test can determine if a person has an infection with hepatitis B. It involves a blood test that detects antigens and antibodies for hepatitis B virus (HBV). Hepatitis B, or hep B, is a ...

When it comes to treating hepatitis C effectively and safely, there is no replacement for antiviral medication. In other words, there are no natural solutions or cures for a hep C infection. That ...

Hepatitis C is the No. 1 cause of liver cancer and liver transplants. It's brought on by a virus you can catch if you come into contact with contaminated blood. You could get it from an unclean tattoo ...

Hepatitis C affects your liver the most, but it can cause problems with other body parts, too, including your skin. Bumps, rashes, and itchy spots may be the first signs you notice of this infection.

Hepatocyte paraffin 1 (Hep Par 1), a murine monoclonal antibody, is widely used in surgical pathology practice to determine the hepatocellular origin of neoplasms. However, identity of the antigen for ...

Greg Dore consults to Gilead, Merck, Abbvie, and Bristol-Myers Squibb. He receives research funding from NHMRC, National Institutes of Health, Australian Government Department of Health, and NSW ...